cancer-therapy

Documents about cancer-therapy

• Ipilimumab and Nivolumab in Patients With Anti-PD-1-axis Therapy-resistant Advanced Non-small Cell Lung Cancer.#143554ClinicalTrials.gov
• Safety and Efficacy of SOX Therapy After Preoperative Chemoradiotherapy for Advanced Lower Rectal Cancer: A Phase I Study.#150057NCBI PubMed Central
• Temozolomide, Memantine Hydrochloride, Mefloquine, and Metformin Hydrochloride in Treating Patients With Glioblastoma Multiforme After Radiation Therapy#152361ClinicalTrials.gov
• Will a Pre-therapy Exercise Intervention Improve the Outcomes of Patients With Advanced Oesophageal Cancer?#152412ClinicalTrials.gov
• Composing drug delivery with light distribution improvement: the use of dissolving microneedles in skin cancer with photodynamic therapy.#170718NCBI PubMed Central
• A deep learning-driven automated treatment planning framework for cervical cancer patients treated with volumetric modulated arc therapy.#185942NCBI PubMed Central
• The Effectiveness Of Acceptance And Commitment Therapy （Act）On Disease Acceptance And Quality Of Life Among Breast Cancer Patients#190865USM Repository
• Cyclophosphamide, TAPA-Pulsed Dendritic Cell Therapy and Imiquimod in Progressive and/or Refractory Solid Malignancies#195327ClinicalTrials.gov
• Zn(ii)-based metal-organic frameworks with tailored architectures: optimizing fluorescence performance for cell imaging and cancer therapy.#199140NCBI PubMed Central
• Toripalimab Combined With Gemcitabine and Cisplatin (GemCis) as Preoperative Neoadjuvant Therapy for Resectable Intrahepatic Cholangiocarcinoma#208321ClinicalTrials.gov
• Dynamic changes in serum HER2-peptide-specific autoantibodies predict response to neoadjuvant therapy in HER2-positive breast cancer.#220970NCBI PubMed Central
• Tertiary lymphoid structures in the era of cancer therapy#257725HAL (France)
• Real-world assessment of quality-of-life in patients with breast cancer treated with adjuvant endocrine therapy.#262814NCBI PubMed Central
• The Application of eHealth in Symptom Management of Patients With Breast Cancer During Endocrine Therapy: Scoping Literature Review.#263156NCBI PubMed Central
• The role of the microbiome in gynecological cancers: implications for diagnosis and treatment#283323Digital Commons @ Michigan Tech
• Integrative multi-omics identifies a glycosylation-based prognostic framework and nominates ALG3 for targeted therapy in bladder cancer.#320504NCBI PubMed Central
• A Novel Therapeutic Approach: Gamma Secretase Inhibitor Enhances Radiotherapy and Checkpoint Blockade Therapy via Reprogramming of the Tumor Microenvironment#325023bioRxiv / medRxiv
• Effect Of Radiotherapy Combined With Capsaicin And Fraxetin As Enhanced Therapy On Colorectal Cancer Cell Line In Vitro#356041USM Repository
• Cancer-Associated Fibroblast-Targeted Nanomedicine in Solid Tumor Therapy: From Mechanisms of Therapeutic Resistance to Precision Stromal Modulation.#362158NCBI PubMed Central
• Induction of Sensecence Using Dexamethasone to Re-sensitize NSCLC to Anti-PD1 Therapy#363612ClinicalTrials.gov
• Development of Second Malignancies Following Chemotherapy With or Without Radiation Therapy for the Treatment of Locally Advanced Rectal Cancer.#382510NCBI PubMed Central
• Mesothelin/GPC3/GUCY2C-CAR-T Cells Against Cancers#383557ClinicalTrials.gov
• Personalised Neoantigen-targeting Cancer Vaccine NECVAX-NEO1 in Anti-PD-1/PD-L1 Therapy in Patients With Solid Tumors#390947ClinicalTrials.gov
• Consolidation of Ultrasound and Light: Silicon Phthalocyanine-Based Sensitizer Therapeutic Agent for Synergetic Sonodynamic-Photodynamic Therapy of Breast Cancer#419916Aperta
• A Study to Prospectively Validate Blood Markers Associated With Differences in Efficacy of Neoadjuvant Therapy for NSCLC#460086ClinicalTrials.gov
• Combined Immunochemotherapy Followed By Reduced Dose Radiation Therapy (RT) for Patients With Newly Diagnosed Primary Central Nervous System Lymphoma#460096ClinicalTrials.gov
• Pembrolizumab Combined With Preoperative Chemotherapy (Albumin Paclitaxel+Carboplatin) Neoadjuvant Therapy for Resectable Locally Advanced (Stage II/III) Esophageal Squamous Cell Carcinoma#463707ClinicalTrials.gov
• Single-cell and spatial omics of metabolic-immune ecosystems in prostate cancer: from androgen signaling to therapy resistance.#476919NCBI PubMed Central
• Cognitive Behavior vs Bright Light Therapy for Insomnia in Women Undergoing Chemotherapy for Breast Cancer: A Randomized Clinical Trial.#610169NCBI PubMed Central
• A novel treatment approach for paediatric Gorham-Stout syndrome with chylothorax#630671Lund University Publications
• Pathway dysregulation and therapeutic resistance in glioblastoma: molecular mechanisms and emerging therapeutic targets#676327Europe PMC
• Burden of Treatment-Induced Vasomotor Symptoms in Men With Prostate Cancer on Androgen-Deprivation Therapy: A Systematic Literature Review.#685758NCBI PubMed Central
• Combination Therapy with HSP90 Inhibitors and NanoPulse Stimulation Synergistically Impedes Hepatocellular Carcinoma and Breast Cancer Growth in Mice#289048ODU Digital Commons
• Quantitative imaging for predicting biological response in 177Lu-PSMA radioligand therapy for metastatic castration-resistant prostate cancer#374353HAL (France)
• A Retrospective Review of Low- and Intermediate-Prostate Cancer Patients Treated with Brachytherapy at Chris Hani Baragwanath Academic Hospital#394011WIReDSpace
• Impact of Axillary Surgery on Outcome of Clinically Node Positive Breast Cancer Treated With Neoadjuvant Chemotherapy#410149Scholar Commons
• Fecal Microbiota Transplant and Re-introduction of Anti-PD-1 Therapy (Pembrolizumab or Nivolumab) for the Treatment of Metastatic Colorectal Cancer in Anti-PD-1 Non-responders#148770ClinicalTrials.gov
• Vaccine Therapy and Cyclophosphamide in Treating Patients With Stage II-III Breast or Stage II-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer#230469ClinicalTrials.gov
• Data for: Neoadjuvant palbociclib and endocrine therapy versus chemotherapy in ER+/HER2- breast cancer: a randomized phase II trial#279164api.researchdata.se
• Do combined resistance and aerobic exercise programs cause an interference effect in women with breast cancer? A systematic review and network meta-analysis#389812Research Online
• Sapanisertib and Nivolumab for the Treatment of Stage I-IV Non-small Cell Lung Cancer in Patients Who Have Progressed on Prior PD-1/PD-L1 Inhibitor Therapy, I-OVERCOME Study#127610ClinicalTrials.gov
• Ipilimumab N01 Plus Sintilimab and Lenvatinib as First-line Therapy for Locally Advanced or Metastatic TFE3-Rearranged Renal Cell Carcinoma: A Prospective, Multicenter, Single-Arm, Phase II Clinical Trial#432896ClinicalTrials.gov
• PET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung Cancer#253003ClinicalTrials.gov
• A Phase III Clinical Study of WX390 Combined With Toripalimab Versus Investigator's Choice of Therapy in Patients With Recurrent or Metastatic Cervical Cancer Who Have Failed Prior Platinum-Based Treatment#272339ClinicalTrials.gov
• An in vitro analysis of brassica oleracea L. var. capitata f. rubra extract coupled with sonodynamic therapy (SDT) on H69PR lung cancer cell lines#366126Animo Repository
• RAPA-201 Therapy of Solid Tumors#426773ClinicalTrials.gov
• Healthcare Provider Perspectives on a Clinical Decision Tool to Support Individualized Exercise Prescriptions and Discussions for Breast Cancer Survivors#465420ODU Digital Commons
• 15th Annual ENBDC Meeting: How do Cellular Potency, Microenvironment and Natural Rhythms Influence Mammary Gland Biology and Breast Cancer?#640279Apollo
• Neoantigen-loaded DC Vaccine and Conventional Third-line Therapy for CRC Progressed After Second-line Treatment#146456ClinicalTrials.gov
• Improving Long-Term Adherence to Endocrine Therapy Among Breast Cancer Survivors: Development of a Multiscale Modeling and Intervention System.#148101NCBI PubMed Central